“Patient-Level, Visit-by-Visit Data Highlight the Extent of Skin and Itch Improvement in Atopic Dermatitis With Lebrikizumab”, J of Skin, vol. 7, no. 6, p. s275, Nov. 2023, doi: 10.25251/skin.7.supp.275.